Drug-induced hemolytic anemia due to cefoperazone-sulbactum: Challenges in reaching diagnosis
- PMID: 36571331
- PMCID: PMC9997613
- DOI: 10.4103/jpgm.jpgm_248_22
Drug-induced hemolytic anemia due to cefoperazone-sulbactum: Challenges in reaching diagnosis
Conflict of interest statement
None
Comment on
-
Cefoperazone/sulbactam-induced hemolytic anemia.J Postgrad Med. 2023 Jan-Mar;69(1):46-49. doi: 10.4103/jpgm.JPGM_1335_20. J Postgrad Med. 2023. PMID: 34528516 Free PMC article.
Similar articles
-
Cefoperazone/sulbactam-induced hemolytic anemia.J Postgrad Med. 2023 Jan-Mar;69(1):46-49. doi: 10.4103/jpgm.JPGM_1335_20. J Postgrad Med. 2023. PMID: 34528516 Free PMC article.
-
A case of immune hemolytic anemia induced by ceftizoxime and cefobactam (sulbactam/cefoperazone).Korean J Lab Med. 2009 Dec;29(6):578-84. doi: 10.3343/kjlm.2009.29.6.578. Korean J Lab Med. 2009. PMID: 20046091
-
Cefoperazone / sulbactam induced hyponatremia.Indian J Med Sci. 2006 Apr;60(4):158-9. Indian J Med Sci. 2006. PMID: 16679632 No abstract available.
-
Drug-induced hemolytic anemia: Pharmacological aspects.Transfus Clin Biol. 2017 Sep;24(3):110-114. doi: 10.1016/j.tracli.2017.05.013. Epub 2017 Jun 23. Transfus Clin Biol. 2017. PMID: 28648734 Review.
-
[Hematological side effects of antimicrobial agents].Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:596-600. Nihon Rinsho. 2007. PMID: 17455687 Review. Japanese. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources